Treatment outcomes for metastatic castrate-resistant prostate cancer (mCRPC) patients (pts) following docetaxel (D) for hormone sensitive disease Conference Paper uri icon

authors

  • Schmidt, Andrew Lachlan
  • Anton, Angelyn
  • Wong, Shirley S
  • Azad, Arun
  • Kwan, Edmond Michael
  • Spain, Lavinia Anne
  • Torres, Javier
  • Muthusamy, Arunbalaji
  • Parente, Phillip
  • Parnis, Francis
  • Goh, Jeffrey C
  • Joshua, Anthony M
  • Pook, David William
  • Gibbs, Peter
  • Tran, Ben
  • Weickhardt, Andrew James

publication date

  • February 20, 2020